We found expression endogenous calpain inhibitors (Gas2 and calpastatin) was also increased in human CD34+CML cells or Bcr-abl-transduced murine progenitors compared with control cells [16, 17]. This evidence concerns the gene GAS2 and chronic myelogenous leukemia, BCR-ABL1 positive.